期刊
PATHOLOGY RESEARCH AND PRACTICE
卷 250, 期 -, 页码 -出版社
ELSEVIER GMBH
DOI: 10.1016/j.prp.2023.154817
关键词
MiRNA; Malignant pleural mesothelioma; MPM; Drug resistance; Diagnosis; Prognosis
类别
This review summarizes and analyzes the latest scholarly investigations on the role of miRNAs in the dysregulation leading to MPM and their potential clinical usefulness as diagnostic and prognostic biomarkers for MPM.
Malignant pleural mesothelioma (MPM) is a highly lethal form of pleural cancer characterized by a scarcity of effective therapeutic interventions, resulting in unfavorable prognoses for afflicted individuals. Besides, many patients experience substantial consequences from being diagnosed in advanced stages. The available diagnostic, prognostic, and therapeutic options for MPM are restricted in scope. MicroRNAs (miRNAs) are a subset of small, noncoding RNA molecules that exert significant regulatory influence over several cellular processes within cell biology. A wide range of miRNAs have atypical expression patterns in cancer, serving specific functions as either tumor suppressors or oncomiRs. This review aims to collate, epitomize, and analyze the latest scholarly investigations on miRNAs that are believed to be implicated in the dysregulation leading to MPM. miRNAs are also discussed concerning their potential clinical usefulness as diagnostic and prognostic biomarkers for MPM. The future holds promising prospects for enhancing diagnostic, prognostic, and therapeutic modalities for MPM, with miRNAs emerging as a potential trigger for such advancements.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据